Keros Therapeutics (KROS) Other Non Operating Income (2019 - 2025)
Keros Therapeutics (KROS) posted Other Non Operating Income of $273000.0 for Q4 2025, up 207.91% on a QoQ basis from -$253000.0 in Q3 2025, and up 219.21% year-over-year from $85522.6 in Q4 2024.
Keros Therapeutics (KROS) Other Non Operating Income (2019 - 2025) Analysis & Trends
Keros Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $273000.0 for Q4 2025.
- Quarterly Other Non Operating Income rose 219.21% year-over-year to $273000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$539000.0 (up 43.5% YoY) and the FY2025 annual result came in at -$539000.0, up 43.5% from the prior year.
- Other Non Operating Income was $273000.0 for Q4 2025 at Keros Therapeutics, up from -$253000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $762000.0 in Q3 2022 and bottomed at -$1.4 million in Q4 2022.
- A 5-year average of -$134750.0 and a median of -$96500.0 in 2021 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 656.2% in 2022, while the deepest fall reached 1288.12% in 2022.
- Keros Therapeutics' Other Non Operating Income stood at -$101000.0 in 2021, then plunged by 1288.12% to -$1.4 million in 2022, then soared by 103.99% to $56000.0 in 2023, then tumbled by 508.93% to -$229000.0 in 2024, then soared by 219.21% to $273000.0 in 2025.
- Business Quant data shows KROS's Other Non Operating Income at $273000.0 in Q4 2025, -$253000.0 in Q3 2025, and -$221000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 273,000.00 |
| Sep 30, 2025 | -253,000.00 |
| Jun 30, 2025 | -221,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Dec 31, 2024 | -229,000.00 |
| Sep 30, 2024 | -92,000.00 |
| Jun 30, 2024 | -196,000.00 |
| Mar 31, 2024 | -437,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | -67,000.00 |
| Jun 30, 2023 | -155,000.00 |
| Mar 31, 2023 | -40,000.00 |
| Dec 31, 2022 | -1.40 Mn |
| Sep 30, 2022 | 762,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Mar 31, 2022 | -59,000.00 |
| Dec 31, 2021 | -101,000.00 |
| Sep 30, 2021 | -137,000.00 |
| Jun 30, 2021 | -80,000.00 |
| Mar 31, 2021 | -65,000.00 |